Clinical Trial Update: Immunogenicity of Novel Oral Poliovirus Vaccine Type 2 (nOPV2), bOPV and IPV [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update assessing the immunogenicity of novel oral poliovirus vaccine type 2 (nOPV2), bOPV, and IPV.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Drugs mentioned

• Inactivated Poliovirus Vaccine (Inactivated Poliovirus Vaccine)
• bivalent oral poliovirus vaccine (bOPV)
• novel oral poliovirus vaccine type 2 (nOPV2) (nOPV2)

Snippet

Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh | Conditions: Polio | Phase 4 | Status: UNKNOWN